 |
|
|
| |
PROTON Study: PSI-7977 QD with PEG/RBV:
12-week Safety, RVR, cEVR, & SVR12 in
Treatment-naïve Patients with HCV GT2 or GT3
|
| |
| |
Reported by Jules Levin
EASL 2011 Berlin March 31-April 3
J Lalezari, E Lawitz, M Rodriguez-Torres, A Sheikh,
B Freilich, DR Nelson, T Hassanein, M Mader,
R Hyland, E Albanis, WT Symonds, MM Berrey
|
| |
|
|
|
|
|
